Martina operates at the forefront of functional developments in Market Access, Pricing & HEOR, Epidemiology and Real World Evidence (RWE) to advance state-of-the-art standards and ensure they are consistently applied and met throughout the organization from drug development, via product launches to lifecycle management.
Together with her leadership team, Martina seeks to integrate novel data-scientific methods to drive efficiencies in medical and commercial data generation, data synthesis and data utilization across BI that provides medical and/or commercial value to customers. Prior to this role, Dr. Flammer was the Vice President, Clinical Development & Medical Affairs for Specialty Care in the United States and the chief medical officer for Boehringer Ingelheim in Canada.
Dr. Flammer joined BI from Pfizer’s New York headquarter where she held various leadership roles in global medical and commercial settings. As global medical lead, she delivered three product launches and had responsibilities in the US as well as Emerging Markets. Martina received three distinguished leadership awards, a Pharmaceutical Executive Best Brand Award and with her team a Prix Gallien for best new molecule.
Dr. Flammer received her MD degree from the University of Vienna and completed post-graduate training in Internal and Emergency Medicine in Austria and the US. She obtained her MBA from the Stern School of Business at New York University with specializations in finance, leadership and global business.